Myriad Genetics | MYGN - Собственный капитал и резервы





Собственный капитал и резервы Изменить Дата
Agilent USD 7.36B 241M 2026-06
Becton, Dickinson and Co. USD 24.42B 283M 2026-06
Bio-Rad Laboratories USD 7.17B 322.6M 2026-06
Bruker USD 2.44B 67M 2026-06
Danaher USD 52.58B 368M 2026-06
Illumina USD 2.84B 162M 2026-06
J&J USD 84.97B 3.78B 2026-06
Mettler Toledo International USD 12.82M 54.71M 2026-06
Myriad Genetics USD 303.9M 33.5M 2026-06
OraSure Technologies USD 317.78M 4.45M 2026-06
Pacific Biosciences Of California USD -33.21M 35.58M 2026-06
Quest Diagnostics USD 7.52B 150M 2026-06
Quidel USD 1.85B 69.1M 2026-03
Repligen USD 2.11B 6.57M 2026-06
Revvity USD 7.18B 67.62M 2026-03
Standard Biotools USD 561.12M 136.83M 2026-03
Thermo Fisher Scientific USD 51.93B 1.6B 2026-03
Veracyte USD 1.39B 44M 2026-06
Waters USD 15.29B 12.73B 2026-03